Peak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics addressing unmet needs in the areas of oncology and inflammation. The company's proprietary toxin, PH-1 or Thailanstatin, a spliceosome modulator is being used to generate its first pipeline of novel ADC product candidates to address unmet needs in cancer patients. Its lead product candidate, PHP-303, is a small molecule awaiting Phase II dose clinical study in the orphan disease Alpha1 anti-trypsin deficiency (AATD). The company is based in Palo Alto, California.
Show more...
首席执行官
员工
6
国家
US
ISIN
US70470P1167
上市
0 Comments
分享你的想法
FAQ
Peak Bio 今天的股价是多少?▼
PKBOW 当前价格为 $0 USD,过去 24 小时上涨了 +0%。在图表上更密切关注 Peak Bio 股价表现。
Peak Bio 的股票代码是什么?▼
根据交易所不同,股票代码可能会有所不同。例如,在 交易所,Peak Bio 的股票以代码 PKBOW 进行交易。
Peak Bio 的市值是多少?▼
今天 Peak Bio 的市值为 2,687.5
Peak Bio 有多少名员工?▼
截至四月 01, 2026,公司共有6名员工。
Peak Bio 属于哪个行业?▼
Peak Bio从事于Professional, Scientific, and Technical Services行业。